Batea Oncology is a biotechnology company focused on the development of new therapeutic solutions for aggressive cancers with low survival. We have developed a medical device called GlioHook for the treatment of glioblastoma, the most common brain tumor, for which there are hardly any therapeutic options and for which 5-year survival is less than 5%.
